The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Lack of association of genetic variations of deoxycytidine kinase with toxicity or survival of non-small cell lung cancer patients treated with gemcitabine plus cisplatin.
Jeong Seon Ryu
No relevant relationships to disclose
Eun Soon Shin
No relevant relationships to disclose
Hyun-Jung Kim
No relevant relationships to disclose
Hae-Seong Nam
No relevant relationships to disclose
Jong-Eun Lee
No relevant relationships to disclose
Joo Han Lim
No relevant relationships to disclose